Skip to Main Content

Paper Details

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
Clin Cancer Res
73
2015
CCLE, ETS, ETS members, ETS transcription factor, ETS transcription factor response gene, ETS-activated cancers, ETS1, EWS, EWS-FLI1-knockdown or -overexpressing cells, Ewing, Ewing Sarcoma, Ewing sarcoma, Ewing sarcoma cells, FLI1, NCI-60, PARP, SLFN11, SLFN11 promoter, breast cancer, breast cancer cells, camptothecin, cancer, cancer cells, leukemia, luciferase, patients, pediatric, colon, breast, and prostate cancers, promoter-luciferase reporter, temozolomide, topoisomerase, transcription start site, tumor

Datasets

Release 1.2